Page last updated: 2024-08-23

dermatan sulfate and Critical Illness

dermatan sulfate has been researched along with Critical Illness in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biesma, DH; Haas, FJ; Leusink, JA; Veth, G; Wester, JP	1
Kox, WJ; Spies, C; Vargas Hein, O	1
Burgess, JK; Chong, BH	1
Guyotat, D; Mahul, P; Mazet, E; Mismetti, P; Reynaud, J; Tardy, B; Tardy-Poncet, B	1
John, G; Mudaliar, Y; Shehabi, Y	1

Reviews

1 review(s) available for dermatan sulfate and Critical Illness

Article	Year
Anticoagulation in continuous renal replacement therapy. Contributions to nephrology, 2004, Volume: 144 Topics: Acute Kidney Injury; Anticoagulants; Chondroitin Sulfates; Citrates; Critical Illness; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Prostaglandins; Renal Replacement Therapy; Sodium Citrate	2004

Trials

1 trial(s) available for dermatan sulfate and Critical Illness

Article	Year
Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia. Chest, 1999, Volume: 115, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Recurrence; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome	1999

Article

Year

Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.

Chest, 1999, Volume: 115, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Recurrence; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome

1999

Other Studies

3 other study(ies) available for dermatan sulfate and Critical Illness

Article	Year
Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients. Intensive care medicine, 2004, Volume: 30, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Combinations; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Risk Factors; Thrombocytopenia; Venous Thrombosis	2004
The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls. European journal of haematology, 1997, Volume: 58, Issue:4 Topics: Adenosine Diphosphate; Adult; Aged; Anticoagulants; Chondroitin Sulfates; Critical Illness; Dalteparin; Dermatan Sulfate; Drug Synergism; Enoxaparin; Epinephrine; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation; Reference Values	1997
Use of a low molecular weight preparation of heparin--ORG 10172 (Lomoparan) in the critically ill. Anaesthesia and intensive care, 1991, Volume: 19, Issue:4 Topics: Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Extracorporeal Circulation; Female; Glycosaminoglycans; Hemofiltration; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Multiple Organ Failure; Renal Dialysis; Thrombocytopenia	1991